A REVIEW OF THE PHARMACOLOGICAL MECHANISM OF TRADITIONAL CHINESE MEDICINE IN THE INTERVENTION OF CORONARY HEART DISEASE AND STROKE

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 10, Issue 6, 2013, Pages 532-537

  Zhang, Wenting ^a   Gao, Kuo ^a   Liu, Jingwei ^a   Zhao, Huihui ^a   Wang, Juan ^a   Li, Yubo ^a   Murtaza, Ghulam ^b   Chen, Jianxin ^a   Wang, Wei ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b COMSATS Institute of Information Technology ^*  (Pakistan)

Author keywords

Brain Heart concurrent treatment; Buyang Huanwu Decoction (BHD); Material basis; Pharmaceutical effect mechanism

Indexed keywords

BUYANG HUANWU; HERBACEOUS AGENT;

BRAIN-HEART CONCURRENT TREATMENT; BUYANG HUANWU DECOCTION (BHD); CEREBROVASCULAR ACCIDENT; CHEMICAL DATABASE; CORONARY ARTERY DISEASE; HUMAN; MATERIAL BASIS; PHARMACEUTICAL EFFECT MECHANISM; REVIEW;

BRAIN-HEART CONCURRENT TREATMENT; BUYANG HUANWU DECOCTION (BHD); MATERIAL BASIS; PHARMACEUTICAL EFFECT MECHANISM;

CORONARY DISEASE; DATABASES, CHEMICAL; DRUGS, CHINESE HERBAL; HUMANS; STROKE;

EID: 84900343665     PISSN: None     EISSN: 25050044     Source Type: Journal    
DOI: 10.4314/ajtcam.v10i6.24     Document Type: Article

References (12)

1. Di, C., Peng, L., and Fangbo, Z. (2013). The Molecular Mechanism of Brain-Heart Concurrent Treatment Based on Data Mining and Network Analysis.China J. Chin. Mater. Med. 38: 93-97.
2. Haibo, L., Yong, P., Lu Qi, H., and Peigen, X. (2012). The method of finding the targets of natural product based on Pubchem database. Trad. Chinese Herbs 43: 2099-2016.
3. Hongbin, X., Liping, L., and Ran, L. (2005). BHD’s modern research progress and application in clinical. Inform. Trad. Chin. Med. 22: 52-54.
4. Huanmei, Z., Yaohuang, L., Bingzhang, J., and Hongmin, L. (2009). Preliminary Correlation Study on the Genetic Polymorphisms of TNF βG252A on Heart Disease (CHD) and Tumor Necrosis Factor Levels. J. Trop. Med., 9: 285-287.
5. Huijuan, F., and Qi, Z. (2007). BHD’s Application in Cardiovascular Diseases. Shanxi Trad. Chin. Med. 28: 1409-1413.
6. Lie, J., Yueqiu, G., and Hailiang, G. (2011). Interleukin gene Polymorphism and Cerebral infarction. Diagn. Theory Prac. 10: 179-181.
7. Meikui, Z., Ling, Y., and Xuewen, Z. (2002). The Research Progress of BHD’s Treatment of Ischemic Stroke [J]. China's Basic Med. J. Trad. Chinese Med. 8: 74-78.
8. Wanxia, W., and Rongheng, L. (2008). BHD’s Mechanism Research. Combine Trad. Chinese Western Med. J. Cardio-cerebrovascul. Disease 6: 574-576.
9. Xiaoqing, Y. (2005a). Theories Talk About BHD’s Treatment Mechanism to Qi Deficiency and Blood Stasis Caused by Stroke. China's Trad. Chinese Med. Emergency,14: 342-343.
10. Xiaoqing, Y. (2005b). Mechanism of BHD in Treating Stroke with Qi Deficiency and Blood Stasis Symptom. China's Trad. Chin. Med. Emergen. 14: 342-343.
11. Yunke, Z. (2006). Ischemic Cerebrovascular Disease of Qi Deficiency and Blood Stasis with BHD. Chinese Med. Res. 19: 9-11.
12. Zehong, X., and Yinghui, W. (2006). BHD’s Research Progress in Nearly Ten Years. Rev. Trad. Chin. Med. 12: 97-100.